Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Gastrointestinal Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06843629
What this trial is testing

Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors

Who this might be right for
Ovarian CancerLung AdenocarcinomaPancreatic Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100
Testing effectiveness (Phase 2)Ended earlyNCT05551117
What this trial is testing

Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

Who this might be right for
Castration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more
MacroGenics 192
Early research (Phase 1)Study completedNCT00094003
What this trial is testing

Study of NS-9 in Patients With Liver Metastases

Who this might be right for
Liver NeoplasmsNeoplasm MetastasisLocal Neoplasm Recurrences
NS Pharma, Inc. 20
Early research (Phase 1)Study completedNCT00921869
What this trial is testing

E7050 Administered Orally to Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Eisai Co., Ltd. 16
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Not applicableStudy completedNCT07744477
What this trial is testing

Validation of Serum Metabolite Differences in Patients With Gallstones and Gallbladder Cancer

Who this might be right for
Gallstone DiseaseGallbladder Malignant Neoplasm
Centre Paul Strauss 230
Not applicableStudy completedNCT04566614
What this trial is testing

Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies

Who this might be right for
Neoplasm, ColorectalNeoplasm of LungNeoplasm, Bladder+3 more
Royal Marsden NHS Foundation Trust 128
Not applicableUnknownNCT05830292
What this trial is testing

Use of DRS Probe and Tracking for In-vivo Application

Who this might be right for
Gastrointestinal Cancer
Imperial College London 20
Very early researchEnded earlyNCT06001372
What this trial is testing

Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers

Who this might be right for
Gastrointestinal CancerDepressionAnxiety
University of Utah 2
Not applicableLooking for participantsNCT05066139
What this trial is testing

Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)

Who this might be right for
Digestive System DiseaseNeoplasms
Centre Paul Strauss 144
Not applicableLooking for participantsNCT06715839
What this trial is testing

Target-specific immunoPET Imaging of Digestive System Carcinoma

Who this might be right for
MalignancyDigestive CancerDigestive System Neoplasm+12 more
RenJi Hospital 400
Post-approval studies (Phase 4)Study completedNCT02216799
What this trial is testing

Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)

Who this might be right for
Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition
King Faisal Specialist Hospital & Research Center 61
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Not applicableLooking for participantsNCT06602167
What this trial is testing

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome

Who this might be right for
CapecitabineHand-foot SyndromeElectroacupuncture+3 more
Affiliated Hospital of Qinghai University 220
Testing effectiveness (Phase 2)Study completedNCT02205047
What this trial is testing

Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Malignant Neoplasm of StomachMalignant Neoplasm of Cardio-esophageal Junction of StomachEpidermal Growth Factor Receptor (EGFR) Protein Overexpression
European Organisation for Research and Treatment of Cancer - EORTC 172
Not applicableUnknownNCT06375928
What this trial is testing

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)

Who this might be right for
Malignant Biliary ObstructionPancreatic Cancer ResectableBiliary Tract Neoplasms
Hospital Universitari de Bellvitge 44
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableStudy completedNCT07319767
What this trial is testing

Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors

Who this might be right for
Breast CancerPancreatic Adenocarcinoma (Ductal Adenocarcinoma)Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)
Shanghai Zhongshan Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Next Page